1-phenylmethyl benzimidazole piperazine derivative

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544370, A61K 31495, C07D40304

Patent

active

056726040

ABSTRACT:
New 1-phenylmethyl enzimidazole piperazine derivatives of general formula ##STR1## are described wherein R.sup.1 and R.sup.2 can be a hydrogen atom, a halogen atom, a short chain alkyl group, a nitro group, and a hydroxy group, and their addition salts with pharmaceutically acceptable acids.
These compounds have pharmacological activity as serotonin 5HT.sub.3 receptor antagonists.

REFERENCES:
patent: 5106857 (1992-04-01), Cale, Jr. et al.
patent: 5256665 (1993-10-01), Orjales-Venero et al.
Iemura et al, Chem. Pharm. Bull, 37(10), pp. 2723-2726 (1989).
Iemura et al, Chem. Pharm. Bull. 37 (4) pp. 967-972 (1989).
Kodama et al., Chemical Abstracts, vol.84, No.44060 (1976) (Abs. for JP 126682, Oct. 4, 1975).
Hasegawa et al., Chemical Abstracts, vol.82, No.156308 (19).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1-phenylmethyl benzimidazole piperazine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1-phenylmethyl benzimidazole piperazine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-phenylmethyl benzimidazole piperazine derivative will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2256793

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.